SCHEMBL8893098

SCHEMBL8893098

O=C1c2ccccc2C(=O)c2c1cc1ccccc1c2[N+](=O)[O-]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.59
TSHR P16473 3/20 0.55
ALDH1A1 P00352 3/20 0.55
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46
STAT6 P42226 1/20 0.46
HIF1A Q16665 1/20 0.46
PHLPP2 Q6ZVD8 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HPGD P15428 1/20 0.44
CASP6 P55212 2/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9621304 0.78 CYP3A4 (0.59) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL11424411 0.78 ALDH1A1 (0.62) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL11515026 0.76 ALDH1A1 (0.56) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL11219106 0.76 ALDH1A1 (0.60) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL29450703 0.75 CYP3A4 (1.00) CYP3A4TSHRALDH1A1SMN1; SMN2TP53
SCHEMBL57759 0.75 CYP3A4 (1.00) CYP3A4TSHRALDH1A1SMN1; SMN2TP53
SCHEMBL7435273 0.75 BCL2 (0.63) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL28076387 0.75 ALDH1A1 (0.55) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL5198467 0.75 TSHR (0.55) CYP3A4TSHRALDH1A1NPC1RAB9A
SCHEMBL11130086 0.73 BCL2 (0.61) CYP3A4ALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5594158-A Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1997-01-14 US disclosed